Cargando…

YKL-40 expression in chronic obstructive pulmonary disease: relation to acute exacerbations and airway remodeling

BACKGROUND: Recent studies suggest that YKL-40, also called chitinase-3-like-1 protein, has been implicated in the pathogenesis of various inflammatory diseases. It is currently unknown, however, whether YKL-40 plays a role in acute exacerbations of chronic obstructive pulmonary disease (AECOPD) and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lai, Tianwen, Wu, Dong, Chen, Min, Cao, Chao, Jing, Zhiliang, Huang, Li, Lv, Yingying, Zhao, Xuanna, Lv, Quanchao, Wang, Yajun, Li, Dongming, Wu, Bin, Shen, Huahao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4806429/ https://www.ncbi.nlm.nih.gov/pubmed/27013031 http://dx.doi.org/10.1186/s12931-016-0338-3

Ejemplares similares

YKL-40 is correlated with FEV(1) and the asthma control test (ACT) in asthmatic patients: influence of treatment
por: Lai, Tianwen, et al.
Publicado: (2015)

Association Between Thyroid Function and Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Huang, Dan, et al.
Publicado: (2021)

The effect of statins on chronic obstructive pulmonary disease exacerbation and mortality: a systematic review and meta-analysis of observational research
por: Cao, Chao, et al.
Publicado: (2015)

SIRT1 protects against urban particulate matter-induced airway inflammation
por: Lai, Tianwen, et al.
Publicado: (2019)

Pulmonary infection control window as a switching point for sequential ventilation in the treatment of COPD patients: a meta-analysis
por: Lv, Yingying, et al.
Publicado: (2017)

Interleukin-31 expression and relation to disease severity in human asthma
por: Lai, Tianwen, et al.
Publicado: (2016)

Elevated expression of placental growth factor is associated with airway-wall vascular remodelling and thickening in smokers with asthma
por: Wu, Dong, et al.
Publicado: (2017)

Serum YKL-40 Levels, Leukocyte Profiles, and Acute Exacerbations of Advanced COPD
por: Popețiu, Romana Olivia, et al.
Publicado: (2023)

Plasm YKL-40 Levels Are Associated with Hypertension in Patients with Obstructive Sleep Apnea
por: Li, Kun, et al.
Publicado: (2019)

Plasma YKL-40 and all-cause mortality in patients with chronic obstructive pulmonary disease
por: Holmgaard, Dennis B, et al.
Publicado: (2013)

Serum YKL-40 and colorectal cancer
por: Cintin, C, et al.
Publicado: (1999)

YKL-40 correlates with the phenotype of asthma
por: Specjalski, Krzysztof, et al.
Publicado: (2015)

Chitinase-like protein YKL-40 correlates with inflammatory phenotypes, anti-asthma responsiveness and future exacerbations
por: Liu, Lei, et al.
Publicado: (2019)

Serum Creatinine to Cystatin C Ratio is an Effective Indicator for Muscle Strength Decline in Men with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Huang, Dan, et al.
Publicado: (2022)

Plasma YKL-40 and NGAL are useful in distinguishing ACO from asthma and COPD
por: Wang, Jing, et al.
Publicado: (2018)

Systemic Immune Modulation in Gliomas: Prognostic Value of Plasma IL-6, YKL-40, and Genetic Variation in YKL-40
por: Holst, Camilla Bjørnbak, et al.
Publicado: (2020)

YKL-40 Protein Correlates with the Phenotype of Asthma
por: Specjalski, Krzysztof, et al.
Publicado: (2015)

Plasma YKL-40 in the spectrum of neurodegenerative dementia
por: Villar-Piqué, Anna, et al.
Publicado: (2019)

Annexin A1 is elevated in patients with COPD and affects lung fibroblast function
por: Lai, Tianwen, et al.
Publicado: (2018)

YKL‐40 is a proposed biomarker of inflammation and remodelling elevated in children with bronchopulmonary dysplasia compared to asthma
por: James, Anna J., et al.
Publicado: (2020)

High Blood Eosinophil and YKL-40 Levels, as Well as Low CXCL9 Levels, are Associated with Increased Readmission in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Peng, Junnan, et al.
Publicado: (2021)

Airway, but not serum or urinary, levels of YKL-40 reflect inflammation in early cystic fibrosis lung disease
por: Fantino, Emmanuelle, et al.
Publicado: (2014)

Myeloid-specific SIRT1 deletion exacerbates airway inflammatory response in a mouse model of allergic asthma
por: Lai, Tianwen, et al.
Publicado: (2021)

Overexpression of chitotriosidase and YKL-40 in peripheral blood and sputum of healthy smokers and patients with chronic obstructive pulmonary disease
por: Majewski, Sebastian, et al.
Publicado: (2019)

Sarcopenia index as a predictor of clinical outcomes among older adult patients with acute exacerbation of chronic obstructive pulmonary disease: a cross-sectional study
por: Zhao, Xuanna, et al.
Publicado: (2023)

YKL-40 - an emerging biomarker in cardiovascular disease and diabetes
por: Rathcke, Camilla N, et al.
Publicado: (2009)

Serum YKL-40 Levels in Patients with Gastric Cancer
por: Itik, Veyis, et al.
Publicado: (2011)

YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias
por: Llorens, Franc, et al.
Publicado: (2017)

YKL-40 as a possible marker of neutrophilic asthma
por: Specjalski, Krzysztof, et al.
Publicado: (2023)

YKL-40 and the Cellular Metabolic Profile in Parkinson’s Disease
por: Gevezova, Maria, et al.
Publicado: (2023)

The different role of YKL-40 in glioblastoma is a function of MGMT promoter methylation status
por: Chen, Wei-jun, et al.
Publicado: (2020)

Conserved YKL-40 changes in mice and humans after postoperative delirium
por: David-Bercholz, Jennifer, et al.
Publicado: (2022)

Human epididymis protein 4 aggravates airway inflammation and remodeling in chronic obstructive pulmonary disease
por: Zhan, Yuan, et al.
Publicado: (2022)

YKL-40 Is Associated With Ultrasound-Determined Carotid Atherosclerotic Plaque Instability
por: Wang, Yu, et al.
Publicado: (2021)

YKL-40, a secreted glycoprotein, promotes tumor angiogenesis
por: Shao, Rong, et al.
Publicado: (2009)

YKL-40 acts as an angiogenic factor to promote tumor angiogenesis
por: Shao, Rong
Publicado: (2013)

Vascular heterogeneity and targeting: the role of YKL-40 in glioblastoma vascularization
por: Shao, Rong, et al.
Publicado: (2015)

Cerebrospinal fluid neurogranin and YKL‐40 as biomarkers of Alzheimer's disease
por: Janelidze, Shorena, et al.
Publicado: (2015)

Prognosis and Reclassification by YKL‐40 in Stable Coronary Artery Disease
por: Schroder, Jakob, et al.
Publicado: (2020)

Effect of Vitamin D on YKL-40: Rat Hypercholesterolemia Model
por: Kocabas, Rahim
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0oiit7ni54d13nv9s31076djjm